Zeronda Tyler 4

What Happened
Zeronda Tyler, Chief Financial Officer of VYNE Therapeutics (VYNE), had 4,007 shares withheld by the company to satisfy tax withholding obligations in connection with the vesting of restricted stock units (RSUs). The withholding was executed at $0.60 per share, totaling $2,394. This was a withholding for taxes (routine) rather than an open-market sale.

Key Details

• Transaction date: 2026-03-31
• Price per share: $0.60; total value withheld: $2,394
• Shares involved: 4,007 shares withheld (disposed by issuer to cover taxes)
• Footnote: F1 — shares withheld by the issuer to satisfy tax withholding requirements upon RSU vesting
• Filing: Form 4 filed with accession 0001867033-26-000004 on 2026-04-02; filing does not indicate tardiness in the provided data
• Shares owned after transaction: Not specified in the provided filing excerpt

Context
This is a common administrative transaction where the company retains a portion of vested RSU shares to cover required tax withholdings (a cashless withholding). It does not represent a voluntary sale into the market and generally does not signal a change in the insider’s investment stance.